Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study.
BMJ Open
; 12(9): e054536, 2022 09 19.
Article
in En
| MEDLINE
| ID: mdl-36123058
Full text:
1
Database:
MEDLINE
Main subject:
Atypical Hemolytic Uremic Syndrome
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Qualitative_research
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
BMJ Open
Year:
2022
Type:
Article
Affiliation country:
United kingdom